Inventor · disambiguated record
Wei Gu
Also filed as: GU WEI · GU WEI-HSIN
17 granted patents·29 pending applications·187 citations·filing 1996–2024
93Inventor score
Files withMILLENNIUM PHARM INC17UNIV COLUMBIA6AMGEN INC2BEIJING GREATWAY PHARMACEUTICAL TECH CO LTD2GU WEI2
Top patents by PatentIndex Score
46 records- 0190US7420624B2Three-dimensional video composite signal demodulating method and system capable of inhibiting pseudo-color noisesSUNPLUS TECHNOLOGY CO LTD·Filed 2005·Granted Sep 2, 2008·16 cites·11 claims
- 0285US5908609AScreening methods for compounds useful in the regulation of body weightMILLENNIUM PHARM INC·Filed 1996·Granted Jun 1, 1999·51 cites·12 claims
- 0380US7358335B2ARF-BP1 as mediator of p53-dependent and independent tumor suppression and uses thereofUNIV COLUMBIA·Filed 2005·Granted Apr 15, 2008·3 cites·6 claims
- 0480US6537765B2GPR10 as a target for identifying weight modulating compoundsMILLENNIUM PHARM INC·Filed 2001·Granted Mar 25, 2003·23 cites·16 claims
- 0573US6190909B1TH2-specific geneMILLENNIUM PHARM INC·Filed 1997·Granted Feb 20, 2001·39 cites·17 claims
- 0670US2011020798A1Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0768US2024408094A1Inhibition of usp7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing foxm1UNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 0867US7241743B2Sir2α-based therapeutic and prophylactic methodsUNIV COLUMBIA·Filed 2002·Granted Jul 10, 2007·2 cites·8 claims
- 0967US2024299347A1Methods and compositions to treat huntington's disease by targeting alox5- mediated ferroptosisUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 1065US2008248477A1Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1165US2024271140A1Lpa inhibitor and use thereofGENOVAL THERAPEUTICS CO LTD·Filed 2024·Application pending·0 cites
- 1265US2004176296A1Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1363US5932779AScreening methods for compounds useful in the regulation of body weightMILLENNIUM PHARM INC·Filed 1997·Granted Aug 3, 1999·27 cites·5 claims
- 1458US2006275870A1Novel G-protein coupled receptors and uses thereforMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 1557US8043804B2DBC1, a novel native inhibitor of anti-aging protein SIRT1UNIV COLUMBIA·Filed 2008·Granted Oct 25, 2011·0 cites·11 claims
- 1657US2023357834A1Hybrid protocols and barcoding schemes for multiple sequencing technologiesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1756US2008009438A9Screening methods for compounds useful in the regulation of body weightMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1855US7502515B2Method for detecting sub-pixel motion for optical navigation deviceSUNPLUS TECHNOLOGY CO LTD·Filed 2004·Granted Mar 10, 2009·9 cites·27 claims
- 1955US2008119434A1Sir2a-based therapeutic and prophylactic methodsTRUSTEES OF COLUBIA UNIVERSITY·Filed 2007·Application pending·0 cites
- 2055US2002072089A1Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforFiled 2001·Application pending·0 cites
- 2152US2023323455A1Methods for assessing the severity and progression of sars-cov2 infections using cell-free dnaUNIV CORNELL·Filed 2021·Application pending·0 cites
- 2252US2006148002A1Methods and compositions for the treatment and diagnosis of body weight disordersGU WEI·Filed 2006·Application pending·0 cites
- 2352US2012070843A1Dbc1, a novel native inhibitor of the anti-aging protein sirt1GU WEI·Filed 2011·Application pending·0 cites
- 2451US6287763B1Screening methods for compounds useful in the regulation of body weightMILLENNIUM PHARM INC·Filed 1997·Granted Sep 11, 2001·10 cites·14 claims
- 2551US6197530B1GPR10 as a target for identifying weight modulating compoundsMILLENNIUM PHARM INC·Filed 1998·Granted Mar 6, 2001·7 cites·22 claims
- 2651US2004058377A1Novel G-protein coupled receptors and uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 2751US2025303189A1Treatment device for performing light-based treatment operationsKONINKLIJKE PHILIPS NV·Filed 2023·Application pending·0 cites
- 2850US11980598B2N-(2-(substituted-naphth-1-yl)ethyl) substituted amide compound, preparation and uses thereofBEIJING GREATWAY PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted May 14, 2024·0 cites·16 claims
- 2950US2022340911A1Rnai constructs for inhibiting slc30a8 expression and methods of use thereofAMGEN INC·Filed 2020·Application pending·0 cites
- 3050US2004029134A1P53-associated Parkin-like cytoplasmic protein, and related compositions and methodsFiled 2002·Application pending·0 cites
- 3150US2006002919A115625 receptor, a novel G-protein coupled receptorMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3249US9267174B2Method of simultaneously screening for multiple genotypes and/or mutationsQUAKE STEPHEN R·Filed 2011·Granted Feb 23, 2016·0 cites·7 claims
- 3349US2003113841A18105, a novel human sugar transporter family member and uses thereofFiled 2002·Application pending·0 cites
- 3448US2004197766A1Methods and compositions for the treatment and diagnosis of body weight disordersMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3548US2023348493A1Compound for adjusting activity of nmda receptor, and pharmaceutical composition and use thereofBEIJING GREATWAY PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 3647US2003166047A1Lgr6 nucleic acids and uses thereofMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 3747US2003232336A1Novel human ion channel and transporter family membersFiled 2002·Application pending·0 cites
- 3846US2003096785A1Control of hunger, satiety, and food intake by modulating expression and activity of cephalic G protein-coupled receptorsMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3945US2002156246A115625 receptor, a novel G-protein coupled receptorMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4041US10795322B2Learning method for smartwatch to prevent metal hand from lightening the screen by unintended touchGUANGDONG APPSCOMM CO LTD·Filed 2019·Granted Oct 6, 2020·0 cites·2 claims
- 4140US2006275285A1Methods of inhibiting a GPCRAMGEN INC·Filed 2006·Application pending·0 cites
- 4239US2018051320A1Depletion of abundant sequences by hybridization (dash)UNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 4338US7498134B2HAUSP-Mdm2 interaction and uses thereofUNIV COLUMBIA·Filed 2004·Granted Mar 3, 2009·0 cites·6 claims
- 4438US2012164137A1Anti-folate receptor alpha antibody glycoformsSASS PHILIP M·Filed 2011·Application pending·0 cites
- 4534US11466013B2ERK inhibitor and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2019·Granted Oct 11, 2022·0 cites·27 claims
- 4632US7425538B2HAUSP-p53 interaction and uses thereofTRUSTESS OF COLUMBIA UNIVERSIT·Filed 2002·Granted Sep 16, 2008·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Wei Gu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →